TPA and NCPA praise Tennessee law banning PBMs from owning pharmacies
“Today marks a historic step forward for patients and pharmacists across Tennessee,” said Anthony Pudlo, CEO of the Tennessee Pharmacists Association.
“Today marks a historic step forward for patients and pharmacists across Tennessee,” said Anthony Pudlo, CEO of the Tennessee Pharmacists Association.
The PBM Kickback Prohibition Act (H.R. 7895), introduced by Rep. Rick Allen (R-Ga.), is being marked up by the House Committee on Education and the Workforce in a hearing this morning.
Independent businesses and farmers unveil affordability agenda centered on stronger competition policy and antitrust enforcement.
The Patients Before Monopolies Act aims squarely at the conflicts of interest created by vertically integrated PBMs by prohibiting a parent company from owning both a PBM/health insurer and a pharmacy,
The event was at maximum capacity for the third year in a row, drawing hundreds of community pharmacists from 43 states and the District of Columbia.
New facility lets NCPA create more engaging content for independent pharmacists on multiple media platforms.
Multi-media blitz emphasizes how big chain drugstores and mail-order operations treat customers like a number rather than a neighbor.
Current system reduces access to pharmacies, increases costs, stifles competition.
Tables begin to turn on PBM after years of squeezing consumers, employers, and independent pharmacies.
Pharmacy organizations are urging lawmakers to act quickly and send the legislation to the White House.
Urges swift progress to President’s desk.
By Doug Hoey, CEO, National Community Pharmacists Association
“We’re glad to have him on our team,” says NCPA CEO.
Wide bipartisan support means no more excuses, says NCPA.
The case revolves around a state law (Act 624) passed earlier this year blocking PBMs in Arkansas from also operating pharmacies in the state.
There are many headwinds for the industry, starting with reimbursement pressure, but also extensive opportunities for collectively modernizing approaches to elevate the role of the pharmacist.